Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a randomized controlled trial

BACKGROUND: Standard treatment for locally advanced rectal cancer includes 5–6 weeks of neoadjuvant chemoradiotherapy (NACRT) followed by total mesorectal excision 6–8 weeks later. NACRT improves local disease control and surgical outcomes but also causes side effects including fatigue, diarrhea, ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Morielli, Andria R., Usmani, Nawaid, Boulé, Normand G., Severin, Diane, Tankel, Keith, Nijjar, Tirath, Joseph, Kurian, Fairchild, Alysa, Courneya, Kerry S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767015/
https://www.ncbi.nlm.nih.gov/pubmed/29329555
http://dx.doi.org/10.1186/s13063-017-2398-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767015/
https://www.ncbi.nlm.nih.gov/pubmed/29329555
http://dx.doi.org/10.1186/s13063-017-2398-1

Ejemplares similares